Centene Corp Files 8-K for Regulation FD Disclosure
Ticker: CNC · Form: 8-K · Filed: 2024-10-11T00:00:00.000Z
Sentiment: neutral
Topics: regulation-fd, disclosure, sec-filing
Related Tickers: CNC
TL;DR
Centene filed an 8-K for a Reg FD disclosure on Oct 11, 2024.
AI Summary
Centene Corporation filed an 8-K on October 11, 2024, to report a Regulation FD Disclosure. The filing date indicates the earliest event reported was October 11, 2024, with a date of change on October 10, 2024. The company is incorporated in Delaware and headquartered in St. Louis, Missouri.
Why It Matters
This filing indicates Centene Corporation is making a public disclosure under Regulation FD, which ensures fair disclosure of material information to all investors.
Risk Assessment
Risk Level: low — This is a standard regulatory filing and does not appear to contain any new material adverse information.
Key Numbers
- 001-31826 — SEC File Number (Identifies the company's filing with the SEC.)
- 42-1406317 — IRS Employer Identification No. (Company's tax identification number.)
Key Players & Entities
- CENTENE CORP (company) — Registrant
- Delaware (jurisdiction) — State of Incorporation
- St. Louis, Missouri (location) — Principal Executive Offices
FAQ
What is the specific nature of the Regulation FD Disclosure being made by Centene Corporation?
The provided text does not specify the exact content of the Regulation FD Disclosure, only that the filing is for this purpose.
What event triggered the 8-K filing on October 11, 2024?
The filing states the date of the earliest event reported is October 11, 2024, but does not detail the specific event.
Has Centene Corporation's principal executive office address changed recently?
The filing lists the principal executive offices at 7700 Forsyth Boulevard, St. Louis, Missouri 63105, and does not indicate a recent change.
What is Centene Corporation's fiscal year end?
Centene Corporation's fiscal year ends on December 31.
Is this filing related to any specific transaction or event beyond a general disclosure?
The filing is categorized under 'Regulation FD Disclosure' and does not explicitly mention any specific transactions like mergers, acquisitions, or earnings announcements.
From the Filing
0001071739-24-000192.txt : 20241011 0001071739-24-000192.hdr.sgml : 20241011 20241010205040 ACCESSION NUMBER: 0001071739-24-000192 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 13 CONFORMED PERIOD OF REPORT: 20241011 ITEM INFORMATION: Regulation FD Disclosure FILED AS OF DATE: 20241011 DATE AS OF CHANGE: 20241010 FILER: COMPANY DATA: COMPANY CONFORMED NAME: CENTENE CORP CENTRAL INDEX KEY: 0001071739 STANDARD INDUSTRIAL CLASSIFICATION: HOSPITAL & MEDICAL SERVICE PLANS [6324] ORGANIZATION NAME: 02 Finance IRS NUMBER: 041406317 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-31826 FILM NUMBER: 241366162 BUSINESS ADDRESS: STREET 1: 7700 FORSYTH BLVD. CITY: ST LOUIS STATE: MO ZIP: 63105 BUSINESS PHONE: 3147254477 MAIL ADDRESS: STREET 1: 7700 FORSYTH BLVD. CITY: ST LOUIS STATE: MO ZIP: 63105 8-K 1 cnc-20241011.htm 8-K cnc-20241011 0001071739 false 0001071739 2024-10-11 2024-10-11 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 11, 2024 CENTENE CORPORATION (Exact Name of Registrant as Specified in Charter) Delaware 001-31826 42-1406317 (State or Other Jurisdiction of Incorporation) (Commission File Number) (IRS Employer Identification No.) 7700 Forsyth Boulevard, St. Louis, Missouri 63105 (Address of Principal Executive Offices) (Zip Code) Registrant's telephone number, including area code: ( 314 ) 725-4477 (Former Name or Former Address, if Changed Since Last Report): N/A Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below): ☐      Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) ☐      Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) ☐      Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) ☐      Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act: Title of each class Trading Symbol(s) Name of each exchange on which registered Common stock, $0.001 Par Value CNC New York Stock Exchange Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).   Emerging growth company  ☐   If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  ☐ ITEM 7.01 REGULATION FD DISCLOSURE The Centers for Medicare and Medicaid Services (CMS) issued 2025 Medicare Advantage Star Ratings on October 10, 2024. Based on the data, Centene Corporation has approximately 46% of its Medicare Advantage membership enrolled in plans rated 3.5 stars or higher – compared to approximately 23% in the prior year. This represents meaningful progress and is consistent with internal expectations despite higher than industry-anticipated cut point changes. Additionally, we are appealing our TTY results with CMS. Forward-Looking Statements All statements, other than statements of current or historical fact, contained in this Form 8-K are forward-looking statements. Without limiting the foregoing, forward-looking statements often use words such as "believe," "anticipate," "plan," "expect," "estimate," "intend," "seek," "tar